FDA DrugClass IINotable
FDA Recall: Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufa
Description
Failed Dissolution Specifications
Hazard
Failed Dissolution Specifications
Remedy
17,304 100-count bottles
Related Recalls
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx o
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactur
Ascend Laboratories, LLC